?>
Contact us
Follow Us
About Us
Members
Executive Director
Why Biosimilars
Biosimilars 101
Policies
Biosimilars are a Free-Market Solution
The Biosimilar Access and Affordability Act
News
Resources
News
Get more out of your business.
Reach it with Microsoft Dynamics 365 Business Central.
News
April 28, 2021
signalgroup
Biosimilars Forum Calls for Bipartisan Policies That Lower Drug Prices on Expensive Biologics Ahead of President Biden’s Joint Session of Congress Address
News
April 27, 2021
signalgroup
Congressmen Tonko and Gibbs Introduce Bipartisan Legislation to Increase Transparency and Use of Biosimilars in Medicare Plans
News
April 26, 2021
signalgroup
President Biden Signs the Advancing Education on Biosimilars Act Into Law
News
April 23, 2021
signalgroup
Congressmen Kurt Schrader and Adam Kinzinger Introduce Bipartisan Legislation to Lower Drug Costs, Incentivize Biosimilars
News
April 14, 2021
signalgroup
Congress Passes Legislation to Lower Health Care Costs Through Bolstering Biosimilars Education
News
April 14, 2021
signalgroup
Biosimilars Forum Member Spotlight: 5 Questions for Viatris
News
April 5, 2021
signalgroup
Value of Biosimilars in Women’s Health: HealthyWomen Roundtable Series Roundup
News
March 23, 2021
signalgroup
The Biosimilars Forum Statement on the 11-Year Anniversary of the ACA and BPCIA
News
March 18, 2021
signalgroup
Biosimilars Forum Statement on The Confirmation of Xavier Becerra As U.S. Secretary of Health And Human Services
News
March 18, 2021
signalgroup
New Economic Report Demonstrates How Biosimilar Competition Lowers Prices
Prev page
08
09
10
11
12
Next page